Literature DB >> 21641616

In healthy young and elderly adults, hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) varies with increasing pharmacological challenge and with age, but not with gender.

Martin Hatzinger1, Serge Brand, Natalie Herzig, Edith Holsboer-Trachsler.   

Abstract

BACKGROUND: Hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) is the key indicator of the psychophysiological response to stress. The HPA AR may vary with age and gender. To investigate these factors concurrently, the aims of the present study were to observe HPA AR (plasma ACTH and plasma cortisol) in response to a pharmacological challenge (dexamethasone/corticotropin releasing hormone test: DEX/CRH-test) and as a function of age and gender.
METHOD: 19 young (10 females and 9 males; mean age = 24.05 years) and 23 elderly (11 females and 12 males; mean age = 71.61 years) healthy volunteers took part in the study. To assess HPA AR, participants underwent the combined DEX/CRH test applied with the following DEX doses: 0.75, 1.5, and 3.0 mg, respectively.
RESULTS: A dose-dependent response was observed in young adult participants, but not in elderly participants. With increasing DEX doses, ACTH and cortisol values decreased in young adult participants, while the decrease was blunted among elderly compared to young adult participants. No differences were observed for gender.
CONCLUSIONS: Results point to diminished HPA axis sensitivity as an effect of normal aging, irrespective of gender. Therefore, altered HPA regulation in old age should be taken into account for developing new therapeutic approaches acting on the HPA axis and its receptor mechanisms.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641616     DOI: 10.1016/j.jpsychires.2011.05.006

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  7 in total

1.  Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy.

Authors:  Jason M Holland; Alan F Schatzberg; Ruth O'Hara; Renee M Marquett; Dolores Gallagher-Thompson
Journal:  Psychiatry Res       Date:  2013-08-14       Impact factor: 3.222

Review 2.  Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis.

Authors:  Johannes D Veldhuis; Animesh Sharma; Ferdinand Roelfsema
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-13       Impact factor: 4.741

3.  Age and the association between negative affective states and diurnal cortisol.

Authors:  Jennifer R Piazza; Susan T Charles; Robert S Stawski; David M Almeida
Journal:  Psychol Aging       Date:  2012-10-22

4.  Glucocorticoid mediated regulation of inflammation in human monocytes is associated with depressive mood and obesity.

Authors:  Tiefu Cheng; Stoyan Dimitrov; Christopher Pruitt; Suzi Hong
Journal:  Psychoneuroendocrinology       Date:  2016-01-12       Impact factor: 4.905

5.  Familial longevity is marked by lower diurnal salivary cortisol levels: the Leiden Longevity Study.

Authors:  Raymond Noordam; Steffy W M Jansen; Abimbola A Akintola; Nicole Y L Oei; Andrea B Maier; Hanno Pijl; P Eline Slagboom; Rudi G J Westendorp; Jeroen van der Grond; Anton J M de Craen; Diana van Heemst
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

Review 6.  Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment.

Authors:  Saswati Paul; Won Kyung Jeon; Jennifer L Bizon; Jung-Soo Han
Journal:  Front Aging Neurosci       Date:  2015-04-02       Impact factor: 5.750

7.  Interleukin-2 drives cortisol secretion in an age-, dose-, and body composition-dependent way.

Authors:  Ferdinand Roelfsema; Peter Y Liu; Rebecca Yang; Paul Takahashi; Johannes D Veldhuis
Journal:  Endocr Connect       Date:  2020-07       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.